TAKHealthcareLarge-Cap
TAKEDA PHARMACEUTICAL CO LTD Insider Trading Activity
Every SEC Form 4 insider transaction reported for TAKEDA PHARMACEUTICAL CO LTD (TAK), sourced directly from SEC EDGAR and updated as new filings are accepted.
By Trabud Research Team · SEC Form 4 & insider trading data analysts
Last updated:
Quick Answer
Are TAK insiders buying or selling?
TAKEDA PHARMACEUTICAL CO LTD insiders reported 0 open-market buys ($0) and 18 sells ($12.4M) across 18 Form 4 filings — a net selling position of $12.4M.
Source: SEC EDGAR Form 4
Key Statistics (as of Sep 4, 2026)
Total Form 4 filings
18
SEC EDGAR
Insider filers
13
Insider buys (0)
$0
Insider sells (18)
$12.4M
Insider sentiment
Net sellingNet insider flow of $12.4M in net selling.
Recent TAK insider transactions
| Date | Insider | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 4, 2026 | Andrew Stewart Plump | President, R&D | Sale | 116.2K | $18.49 | $2.1M |
| Aug 21, 2026 | Andrew Stewart Plump | President, R&D | Sale | 19.7K | $18.49 | $363.3K |
| Aug 19, 2026 | Nicola Deidre Petal Greenway | Chief Human Resources Officer | Sale | 13.0K | $18.11 | $235.1K |
| Aug 13, 2026 | Awny Samaan Botros Farajallah | Chief Medical Officer | Sale | 14.0K | $17.10 | $239.5K |
| Aug 13, 2026 | Ramy Riad Ahmed Ibrahim | President, PDT BU | Sale | 7.3K | $17.10 | $124.4K |
| Aug 13, 2026 | Rhonda Janice Pacheco | President, U.S. Business Unit | Sale | 16.9K | $17.10 | $289.0K |
| Aug 13, 2026 | Lauren Rusckowski Duprey | Chief Transformation Officer | Sale | 47.6K | $17.10 | $813.7K |
| Aug 13, 2026 | Andrew Stewart Plump | President, R&D | Sale | 165.4K | $17.10 | $2.8M |
| Aug 13, 2026 | Agosti Marcello Pignagnoli | Head, Strat. & Port. Dev | Sale | 23.0K | $17.10 | $392.6K |
| Aug 13, 2026 | Teresa Marie Bitetti | President, OBU | Sale | 50.0K | $17.10 | $855.2K |
| Aug 13, 2026 | Elaine Mary Shannon | Pres., Global Supply & Quality | Sale | 4.0K | $17.10 | $68.0K |
| Aug 13, 2026 | Gabriele Ricci | Chief Data & Tech. Officer | Sale | 25.1K | $17.10 | $429.0K |
| Aug 13, 2026 | Nicola Deidre Petal Greenway | Chief Human Resources Officer | Sale | 6.8K | $17.10 | $115.8K |
| Aug 13, 2026 | Julie So-Young Kim | President and CEO | Sale | 89.1K | $17.10 | $1.5M |
| Aug 13, 2026 | Giles Richard Platford | President, IBU | Sale | 31.1K | $17.10 | $531.5K |
| Aug 13, 2026 | Natalie Anne Marie Furney | Global General Counsel | Sale | 30.9K | $17.10 | $527.8K |
| Aug 12, 2026 | Elaine Mary Shannon | Pres., Global Supply & Quality | Sale | 20.4K | $17.55 | $357.4K |
| Aug 12, 2026 | Nicola Deidre Petal Greenway | Chief Human Resources Officer | Sale | 34.6K | $17.51 | $605.8K |
Showing the 18 most recent of 18 Form 4 filings for TAKEDA PHARMACEUTICAL CO LTD.
Most active TAK insiders
- Andrew Stewart Plump3 filings
- Nicola Deidre Petal Greenway3 filings
- Elaine Mary Shannon2 filings
- Agosti Marcello Pignagnoli1 filing
- Awny Samaan Botros Farajallah1 filing
Ask anything about TAK insider activity
Use Trabud's AI agent to query TAKEDA PHARMACEUTICAL CO LTD's Form 4 history in plain English — "Show me TAK CEO purchases this year" or compare it against any other ticker.
Open the AI agentTAK insider trading FAQ
Are TAKEDA PHARMACEUTICAL CO LTD insiders buying or selling?
Across 18 SEC Form 4 filings, TAKEDA PHARMACEUTICAL CO LTD (TAK) insiders reported 0 open-market purchases totaling $0 and 18 sales totaling $12.4M. That is a net selling position of $12.4M.
How many insiders trade TAK stock?
13 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for TAKEDA PHARMACEUTICAL CO LTD. The most recent filing was accepted on Sep 4, 2026.
Where does Trabud get TAK insider trading data?
All TAK insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.
Looking for another company? Browse all tracked companies.